Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy

Aberrant expression of genes contributes to the chemoresistance of colorectal cancer (CRC) treatment. This study aimed to identify genes associated with the chemoresistance of oxaliplatin-based chemotherapy in CRC patients and to construct a signature. Oxaliplatin resistance-related genes were scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yixin, Li, Siqi, Liang, Xinqiang, Li, Kezhi, Xie, Mingzhi, Hu, Bangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503614/
https://www.ncbi.nlm.nih.gov/pubmed/36145360
http://dx.doi.org/10.3390/ph15091139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503614/
https://www.ncbi.nlm.nih.gov/pubmed/36145360
http://dx.doi.org/10.3390/ph15091139

Ejemplares similares